Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

被引:6
|
作者
Marin-Romero, Samira [1 ]
Elias-Hernandez, Teresa [1 ]
Isabel Asensio-Cruz, Maria [1 ]
Ortega-Rivera, Rocio [1 ]
Morillo-Guerrero, Raquel [2 ]
Toral, Javier [3 ]
Montero, Emilio [3 ]
Sanchez, Veronica [4 ]
Arellano, Elena [4 ]
Sanchez-Diaz, Jose Maria [1 ]
Real-Dominguez, Macarena [5 ]
Otero-Candelera, Remedios [1 ]
Jara-Palomares, Luis [1 ,6 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Hosp Ramon & Cajal, Serv Neumol, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Unidad Urgencias & Emergencias, Seville, Spain
[4] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[5] Univ Malaga, Dept Med Prevent & Salud Publ, Malaga, Spain
[6] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 12期
关键词
Decision support techniques; Venous thromboembolism; Validation studies (Publication type); Pulmonary embolism; Venous thrombosis; ACUTE PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; DIAGNOSIS; THROMBOSIS; DURATION; RATES; RULE; COHORT; MODEL;
D O I
10.1016/j.arbres.2019.03.025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Scales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months. Methods: This was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration). Results: Of 353 patients evaluated, 195 were analyzed, with an average age of 53.5 +/- 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p < .05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p < .05). Conclusions: Our study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). (C) 2019 SEPAR. Published by Elsevier Espana. S.L.U. All rights reserved.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 50 条
  • [31] Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism
    Antonio Nieto, Jose
    Solano, Rosario
    Trapero Iglesias, Natacha
    Ruiz-Gimenez, Nuria
    Fernandez-Capitan, Carmen
    Valero, Beatriz
    Tiberio, Gregorio
    Bura-Riviere, Alessandra
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2013, 132 (02) : 175 - 179
  • [32] Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.
    Young, Annie
    Phillips, Jenny
    Hancocks, Helen
    Marshall, Andrea
    Grumett, Joanne
    Dunn, Janet
    Chapman, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism
    Wells, Philip S.
    Kovacs, Michael J.
    Anderson, David
    Kahn, Susan R.
    Kearon, Clive
    Schulman, Sam
    Keeling, David M.
    Kaatz, Scott
    Solymoss, Susan
    Corsi, Daniel
    Rodger, Marc
    BLOOD, 2016, 128 (22)
  • [34] Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
    Caiano, Lucia
    Sharkey, Rhys
    Rodger, Marc A.
    Kovacs, Michael J.
    Le Gal, Gregoire
    Delluc, Aurelien
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (02)
  • [35] Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores
    van Es, Nick
    Wells, Philip S.
    Carrier, Marc
    THROMBOSIS RESEARCH, 2017, 152 : 52 - 60
  • [36] The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study
    Kyrle, P. A.
    Kammer, M.
    Eischer, L.
    Weltermann, A.
    Minar, E.
    Hirschl, M.
    Heinze, G.
    Eichinger, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (12) : 2402 - 2409
  • [37] the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study
    Kyrle, Paul A.
    Kammer, Michael
    Eischer, Lisbeth
    Heinze, Georg
    Eichinger, Sabine
    BLOOD, 2016, 128 (22)
  • [38] Management of patients with venous thromboembolism and a high recurrence risk estimated by the Vienna Prediction Model: a prospective cohort study
    Sinkovec, Hana
    Kyrle, Paul A.
    Eischer, Lisbeth
    Gressenberger, Paul
    Gary, Thomas
    Brodmann, Marianne
    Heinze, Georg
    Eichinger, Sabine
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (01)
  • [40] Association between venous thromboembolism (VTE) minor risk factors and the risk of recurrence after a first unprovoked episode
    Farren-Dai, L.
    Gal, G. L.
    Carrier, M.
    Rodger, M.
    Kovacs, M. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 979 - 979